UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2016, ISBN 9780773548701, ix, 305 pages
Canada History | Harper, Stephen, 1959- Influence | Harper, Stephen, 1959 | Canada Politics and government | Canada - Politique et gouvernement - 2006-2015 | Canada | Canada - History - 21st century | History | Canada - Politics and government - 2006-2015 | Harper, Stephen, - 1959 | Harper, Stephen, - 1959- - Influence | Canada - Histoire - 21e siècle | 21st century | Influence | 2006–2015 | Politics and government | Political Science | Canada-History-21st century | Harper, Stephen,-1959
Book
The New England journal of medicine, ISSN 0028-4793, 02/2008, Volume 358, Issue 7, pp. 676 - 688
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Gadolinium | Male | Immunoglobulins - blood | Adult | Female | B-Lymphocytes - metabolism | Multiple Sclerosis, Relapsing-Remitting - pathology | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Antibodies, Monoclonal - pharmacology | Rituximab | Remission Induction | B-Lymphocytes - drug effects | Magnetic Resonance Imaging | B-Lymphocytes - immunology | Adolescent | Brain - pathology | Immunologic Factors - adverse effects | Infusions, Intravenous | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Causes of | B cells | Drug therapy | Health aspects | Sclerosis | Disability | Multiple sclerosis | Cytokines | Lymphocytes | Patients | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1732 - 20
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | AIDS Vaccines - immunology | Clonal Anergy | Male | Macaca mulatta | HIV Antibodies - biosynthesis | Female | B-Lymphocytes - cytology | Immunization - methods | Immune Tolerance | Models, Molecular | Mice, Transgenic | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | Gene Knock-In Techniques | HIV-1 - immunology | Animals | B-Lymphocytes - immunology | Antibodies, Neutralizing - biosynthesis | Antibodies, Neutralizing - chemistry | Mice | HIV Antibodies - genetics | Binding Sites, Antibody | CD4 Antigens - metabolism | Cell Lineage - immunology | Immunization | Anergy | Vaccination | Antibodies | Trimers | Vaccines | Immunological tolerance | CD4 antigen | Clonal deletion | Lymphocytes B | Neutralizing | Human immunodeficiency virus--HIV | Mutation | Binding sites | Index Medicus | protein vaccines | HIV infections | peripheral tolerance | B-cell receptor | BASIC BIOLOGICAL SCIENCES
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 06/2018, Volume 19, Issue 6, p. 1758
Primary cutaneous diffuse large B-cell lymphoma | Ibrutinib | Leg type | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Genomic Instability | Pyrazoles - therapeutic use | Skin Neoplasms - drug therapy | Humans | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | I-kappa B Proteins - genetics | CARD Signaling Adaptor Proteins - genetics | Aged, 80 and over | Female | Skin Neoplasms - pathology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Pyrimidines - administration & dosage | Interferon Regulatory Factors - genetics | Proto-Oncogene Proteins - genetics | Lymphatic Metastasis | Disease Progression | Pyrazoles - administration & dosage | Pyrimidines - therapeutic use | Skin Neoplasms - genetics | Guanylate Cyclase - genetics | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Pathogenesis | B-cell receptor | Drug resistance | Lymph nodes | Proteins | Skin diseases | Pretreatment | Protein-tyrosine kinase | Tyrosine | NF-κB protein | Immunoglobulins | Genomic analysis | Radiation therapy | Bruton's tyrosine kinase | Patients | Lymphoma | Leg | Molecular modelling | Lymphocytes B | Heavy chains | MyD88 protein | Tumors | Apoptosis | B-cell lymphoma | primary cutaneous diffuse large B-cell lymphoma, leg type | ibrutinib
Journal Article
Science translational medicine, ISSN 1946-6234, 02/2018, Volume 10, Issue 428, p. eaan8405
Journal Article
2010, 1st ed., Blackwell handbooks in linguistics, ISBN 1405155817, Volume 57, xxii, 775
Book
Science translational medicine, ISSN 1946-6234, 02/2018, Volume 10, Issue 428
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 322 - 333
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Organic mental disorders. Neuropsychology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article
BMC medical genomics, ISSN 1755-8794, 05/2014, Volume 7, Issue 1, pp. 23 - 23
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Uracil-DNA Glycosidase - metabolism | Prospective Studies | Humans | Templates, Genetic | False Positive Reactions | Mutation - genetics | Sequence Analysis, DNA | Formaldehyde | Paraffin Embedding | Artifacts | Neoplasms - genetics | DNA Fragmentation | Polymerase Chain Reaction | Cell Line, Tumor | Tissue Fixation | High-Throughput Nucleotide Sequencing - methods | Genetic research | Pathology | Medical research | Hospitals | DNA damage | Colleges & universities | Genetic testing | Gene expression | Epidemiology | Patients | Deoxyribonucleic acid--DNA | Tumors | Cancer | Index Medicus
Journal Article